nodes	percent_of_prediction	percent_of_DWPC	metapath
Emedastine—Keratitis—Erlotinib—pancreatic cancer	0.0382	0.0382	CcSEcCtD
Emedastine—Lacrimation—Irinotecan—pancreatic cancer	0.0301	0.0301	CcSEcCtD
Emedastine—Lacrimation—Fluorouracil—pancreatic cancer	0.0288	0.0288	CcSEcCtD
Emedastine—Lacrimation increased—Sunitinib—pancreatic cancer	0.0233	0.0233	CcSEcCtD
Emedastine—Dry eye—Erlotinib—pancreatic cancer	0.0229	0.0229	CcSEcCtD
Emedastine—Stinging—Fluorouracil—pancreatic cancer	0.0209	0.0209	CcSEcCtD
Emedastine—Lacrimation—Docetaxel—pancreatic cancer	0.0208	0.0208	CcSEcCtD
Emedastine—Eye irritation—Fluorouracil—pancreatic cancer	0.0198	0.0198	CcSEcCtD
Emedastine—Lacrimation increased—Irinotecan—pancreatic cancer	0.0192	0.0192	CcSEcCtD
Emedastine—Lacrimation increased—Fluorouracil—pancreatic cancer	0.0184	0.0184	CcSEcCtD
Emedastine—Eye irritation—Docetaxel—pancreatic cancer	0.0143	0.0143	CcSEcCtD
Emedastine—Lacrimation—Epirubicin—pancreatic cancer	0.014	0.014	CcSEcCtD
Emedastine—Lacrimation increased—Docetaxel—pancreatic cancer	0.0133	0.0133	CcSEcCtD
Emedastine—Sinusitis—Tamoxifen—pancreatic cancer	0.0132	0.0132	CcSEcCtD
Emedastine—Lacrimation—Doxorubicin—pancreatic cancer	0.013	0.013	CcSEcCtD
Emedastine—Keratitis—Epirubicin—pancreatic cancer	0.0127	0.0127	CcSEcCtD
Emedastine—Keratitis—Doxorubicin—pancreatic cancer	0.0118	0.0118	CcSEcCtD
Emedastine—Eye disorder—Erlotinib—pancreatic cancer	0.0116	0.0116	CcSEcCtD
Emedastine—Mental disorder—Erlotinib—pancreatic cancer	0.0109	0.0109	CcSEcCtD
Emedastine—Dysgeusia—Tamoxifen—pancreatic cancer	0.0107	0.0107	CcSEcCtD
Emedastine—Stinging—Epirubicin—pancreatic cancer	0.0102	0.0102	CcSEcCtD
Emedastine—Eye disorder—Sunitinib—pancreatic cancer	0.0101	0.0101	CcSEcCtD
Emedastine—Cardiac disorder—Sunitinib—pancreatic cancer	0.01	0.01	CcSEcCtD
Emedastine—Mental disorder—Sunitinib—pancreatic cancer	0.00944	0.00944	CcSEcCtD
Emedastine—Stinging—Doxorubicin—pancreatic cancer	0.00942	0.00942	CcSEcCtD
Emedastine—Discomfort—Tamoxifen—pancreatic cancer	0.00921	0.00921	CcSEcCtD
Emedastine—Dysgeusia—Sunitinib—pancreatic cancer	0.00919	0.00919	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00916	0.00916	CcSEcCtD
Emedastine—Lacrimation increased—Epirubicin—pancreatic cancer	0.00895	0.00895	CcSEcCtD
Emedastine—Rhinitis—Irinotecan—pancreatic cancer	0.0089	0.0089	CcSEcCtD
Emedastine—Sinusitis—Fluorouracil—pancreatic cancer	0.00889	0.00889	CcSEcCtD
Emedastine—Nervous system disorder—Erlotinib—pancreatic cancer	0.00868	0.00868	CcSEcCtD
Emedastine—Rhinitis—Gemcitabine—pancreatic cancer	0.00867	0.00867	CcSEcCtD
Emedastine—Skin disorder—Erlotinib—pancreatic cancer	0.00859	0.00859	CcSEcCtD
Emedastine—Rhinitis—Fluorouracil—pancreatic cancer	0.00853	0.00853	CcSEcCtD
Emedastine—Lacrimation increased—Doxorubicin—pancreatic cancer	0.00828	0.00828	CcSEcCtD
Emedastine—Cardiac disorder—Irinotecan—pancreatic cancer	0.00824	0.00824	CcSEcCtD
Emedastine—Abnormal dreams—Epirubicin—pancreatic cancer	0.00815	0.00815	CcSEcCtD
Emedastine—Cardiac disorder—Gemcitabine—pancreatic cancer	0.00803	0.00803	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.00793	0.00793	CcSEcCtD
Emedastine—Pain—Tamoxifen—pancreatic cancer	0.00765	0.00765	CcSEcCtD
Emedastine—Dry eye—Epirubicin—pancreatic cancer	0.00761	0.00761	CcSEcCtD
Emedastine—Pain—Erlotinib—pancreatic cancer	0.00756	0.00756	CcSEcCtD
Emedastine—Abnormal dreams—Doxorubicin—pancreatic cancer	0.00754	0.00754	CcSEcCtD
Emedastine—Nervous system disorder—Sunitinib—pancreatic cancer	0.00751	0.00751	CcSEcCtD
Emedastine—Skin disorder—Sunitinib—pancreatic cancer	0.00744	0.00744	CcSEcCtD
Emedastine—Dry eye—Doxorubicin—pancreatic cancer	0.00705	0.00705	CcSEcCtD
Emedastine—Vision blurred—Fluorouracil—pancreatic cancer	0.00698	0.00698	CcSEcCtD
Emedastine—Eye pain—Epirubicin—pancreatic cancer	0.00663	0.00663	CcSEcCtD
Emedastine—Pain—Sunitinib—pancreatic cancer	0.00655	0.00655	CcSEcCtD
Emedastine—Discomfort—Irinotecan—pancreatic cancer	0.0065	0.0065	CcSEcCtD
Emedastine—Asthenia—Tamoxifen—pancreatic cancer	0.00641	0.00641	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00637	0.00637	CcSEcCtD
Emedastine—Asthenia—Erlotinib—pancreatic cancer	0.00635	0.00635	CcSEcCtD
Emedastine—Discomfort—Gemcitabine—pancreatic cancer	0.00633	0.00633	CcSEcCtD
Emedastine—Pruritus—Tamoxifen—pancreatic cancer	0.00633	0.00633	CcSEcCtD
Emedastine—Pruritus—Erlotinib—pancreatic cancer	0.00626	0.00626	CcSEcCtD
Emedastine—Discomfort—Fluorouracil—pancreatic cancer	0.00623	0.00623	CcSEcCtD
Emedastine—Nervous system disorder—Irinotecan—pancreatic cancer	0.00619	0.00619	CcSEcCtD
Emedastine—Rhinitis—Docetaxel—pancreatic cancer	0.00615	0.00615	CcSEcCtD
Emedastine—Eye pain—Doxorubicin—pancreatic cancer	0.00613	0.00613	CcSEcCtD
Emedastine—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00603	0.00603	CcSEcCtD
Emedastine—Skin disorder—Gemcitabine—pancreatic cancer	0.00597	0.00597	CcSEcCtD
Emedastine—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00592	0.00592	CcSEcCtD
Emedastine—Tachycardia—Fluorouracil—pancreatic cancer	0.0059	0.0059	CcSEcCtD
Emedastine—Eye disorder—Docetaxel—pancreatic cancer	0.00574	0.00574	CcSEcCtD
Emedastine—Cardiac disorder—Docetaxel—pancreatic cancer	0.0057	0.0057	CcSEcCtD
Emedastine—Rash—Tamoxifen—pancreatic cancer	0.00564	0.00564	CcSEcCtD
Emedastine—Dermatitis—Tamoxifen—pancreatic cancer	0.00563	0.00563	CcSEcCtD
Emedastine—Headache—Tamoxifen—pancreatic cancer	0.0056	0.0056	CcSEcCtD
Emedastine—Rash—Erlotinib—pancreatic cancer	0.00558	0.00558	CcSEcCtD
Emedastine—Dermatitis—Erlotinib—pancreatic cancer	0.00557	0.00557	CcSEcCtD
Emedastine—Headache—Erlotinib—pancreatic cancer	0.00554	0.00554	CcSEcCtD
Emedastine—Asthenia—Sunitinib—pancreatic cancer	0.00549	0.00549	CcSEcCtD
Emedastine—Pruritus—Sunitinib—pancreatic cancer	0.00542	0.00542	CcSEcCtD
Emedastine—Pain—Irinotecan—pancreatic cancer	0.00539	0.00539	CcSEcCtD
Emedastine—Mental disorder—Docetaxel—pancreatic cancer	0.00538	0.00538	CcSEcCtD
Emedastine—Pain—Gemcitabine—pancreatic cancer	0.00525	0.00525	CcSEcCtD
Emedastine—Dysgeusia—Docetaxel—pancreatic cancer	0.00523	0.00523	CcSEcCtD
Emedastine—Pain—Fluorouracil—pancreatic cancer	0.00517	0.00517	CcSEcCtD
Emedastine—Rash—Sunitinib—pancreatic cancer	0.00483	0.00483	CcSEcCtD
Emedastine—Dermatitis—Sunitinib—pancreatic cancer	0.00482	0.00482	CcSEcCtD
Emedastine—Headache—Sunitinib—pancreatic cancer	0.0048	0.0048	CcSEcCtD
Emedastine—Asthenia—Irinotecan—pancreatic cancer	0.00453	0.00453	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00452	0.00452	CcSEcCtD
Emedastine—Asthenia—Gemcitabine—pancreatic cancer	0.00441	0.00441	CcSEcCtD
Emedastine—Pruritus—Gemcitabine—pancreatic cancer	0.00435	0.00435	CcSEcCtD
Emedastine—Sinusitis—Epirubicin—pancreatic cancer	0.00433	0.00433	CcSEcCtD
Emedastine—Nervous system disorder—Docetaxel—pancreatic cancer	0.00428	0.00428	CcSEcCtD
Emedastine—Pruritus—Fluorouracil—pancreatic cancer	0.00427	0.00427	CcSEcCtD
Emedastine—Tachycardia—Docetaxel—pancreatic cancer	0.00426	0.00426	CcSEcCtD
Emedastine—Skin disorder—Docetaxel—pancreatic cancer	0.00424	0.00424	CcSEcCtD
Emedastine—Rhinitis—Epirubicin—pancreatic cancer	0.00415	0.00415	CcSEcCtD
Emedastine—Sinusitis—Doxorubicin—pancreatic cancer	0.004	0.004	CcSEcCtD
Emedastine—Rash—Irinotecan—pancreatic cancer	0.00398	0.00398	CcSEcCtD
Emedastine—Dermatitis—Irinotecan—pancreatic cancer	0.00397	0.00397	CcSEcCtD
Emedastine—Headache—Irinotecan—pancreatic cancer	0.00395	0.00395	CcSEcCtD
Emedastine—Rash—Gemcitabine—pancreatic cancer	0.00387	0.00387	CcSEcCtD
Emedastine—Dermatitis—Gemcitabine—pancreatic cancer	0.00387	0.00387	CcSEcCtD
Emedastine—Eye disorder—Epirubicin—pancreatic cancer	0.00387	0.00387	CcSEcCtD
Emedastine—Headache—Gemcitabine—pancreatic cancer	0.00385	0.00385	CcSEcCtD
Emedastine—Cardiac disorder—Epirubicin—pancreatic cancer	0.00384	0.00384	CcSEcCtD
Emedastine—Rhinitis—Doxorubicin—pancreatic cancer	0.00384	0.00384	CcSEcCtD
Emedastine—Rash—Fluorouracil—pancreatic cancer	0.00381	0.00381	CcSEcCtD
Emedastine—Dermatitis—Fluorouracil—pancreatic cancer	0.00381	0.00381	CcSEcCtD
Emedastine—Headache—Fluorouracil—pancreatic cancer	0.00378	0.00378	CcSEcCtD
Emedastine—Pain—Docetaxel—pancreatic cancer	0.00373	0.00373	CcSEcCtD
Emedastine—Mental disorder—Epirubicin—pancreatic cancer	0.00363	0.00363	CcSEcCtD
Emedastine—Eye disorder—Doxorubicin—pancreatic cancer	0.00358	0.00358	CcSEcCtD
Emedastine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.00355	0.00355	CcSEcCtD
Emedastine—Dysgeusia—Epirubicin—pancreatic cancer	0.00353	0.00353	CcSEcCtD
Emedastine—Vision blurred—Epirubicin—pancreatic cancer	0.0034	0.0034	CcSEcCtD
Emedastine—Mental disorder—Doxorubicin—pancreatic cancer	0.00336	0.00336	CcSEcCtD
Emedastine—Dysgeusia—Doxorubicin—pancreatic cancer	0.00327	0.00327	CcSEcCtD
Emedastine—Vision blurred—Doxorubicin—pancreatic cancer	0.00314	0.00314	CcSEcCtD
Emedastine—Asthenia—Docetaxel—pancreatic cancer	0.00313	0.00313	CcSEcCtD
Emedastine—Pruritus—Docetaxel—pancreatic cancer	0.00308	0.00308	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.00305	0.00305	CcSEcCtD
Emedastine—Discomfort—Epirubicin—pancreatic cancer	0.00303	0.00303	CcSEcCtD
Emedastine—Nervous system disorder—Epirubicin—pancreatic cancer	0.00288	0.00288	CcSEcCtD
Emedastine—Tachycardia—Epirubicin—pancreatic cancer	0.00287	0.00287	CcSEcCtD
Emedastine—Skin disorder—Epirubicin—pancreatic cancer	0.00286	0.00286	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00282	0.00282	CcSEcCtD
Emedastine—Discomfort—Doxorubicin—pancreatic cancer	0.0028	0.0028	CcSEcCtD
Emedastine—Rash—Docetaxel—pancreatic cancer	0.00275	0.00275	CcSEcCtD
Emedastine—Dermatitis—Docetaxel—pancreatic cancer	0.00275	0.00275	CcSEcCtD
Emedastine—Headache—Docetaxel—pancreatic cancer	0.00273	0.00273	CcSEcCtD
Emedastine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00267	0.00267	CcSEcCtD
Emedastine—Tachycardia—Doxorubicin—pancreatic cancer	0.00266	0.00266	CcSEcCtD
Emedastine—Skin disorder—Doxorubicin—pancreatic cancer	0.00264	0.00264	CcSEcCtD
Emedastine—Pain—Epirubicin—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Emedastine—Pain—Doxorubicin—pancreatic cancer	0.00233	0.00233	CcSEcCtD
Emedastine—Asthenia—Epirubicin—pancreatic cancer	0.00211	0.00211	CcSEcCtD
Emedastine—Pruritus—Epirubicin—pancreatic cancer	0.00208	0.00208	CcSEcCtD
Emedastine—Asthenia—Doxorubicin—pancreatic cancer	0.00195	0.00195	CcSEcCtD
Emedastine—Pruritus—Doxorubicin—pancreatic cancer	0.00193	0.00193	CcSEcCtD
Emedastine—Rash—Epirubicin—pancreatic cancer	0.00185	0.00185	CcSEcCtD
Emedastine—Dermatitis—Epirubicin—pancreatic cancer	0.00185	0.00185	CcSEcCtD
Emedastine—Headache—Epirubicin—pancreatic cancer	0.00184	0.00184	CcSEcCtD
Emedastine—Rash—Doxorubicin—pancreatic cancer	0.00172	0.00172	CcSEcCtD
Emedastine—Dermatitis—Doxorubicin—pancreatic cancer	0.00171	0.00171	CcSEcCtD
Emedastine—Headache—Doxorubicin—pancreatic cancer	0.0017	0.0017	CcSEcCtD
